The Patent Finder

Avacta Life Sciences Limited

3 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Apr 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Scaffold Proteins (US 11,952,415) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 3 of 3

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,447,170Modified Stefin a Scaffold Proteins
In force
 · High confidence
In forceHigh confidence
US 12,286,468Scaffold Proteins
In force
 · Medium confidence
In forceMedium confidence
US 11,952,415Scaffold Proteins
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 3: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 2 no status recorded

Showing 1 to 9 of 9, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/081,010Scaffold ProteinsMar 17, 2025Pending
18/698,634Oct 6, 2022No status recorded
18/698,618PD-L1 Binding AffimersOct 6, 2022Pending
18/034,225Fap-Activated Serum Extended Half-Life Therapeutic ConjugatesOct 29, 2021Pending
18/034,221Enzyme-Activated Serum Extended Half-Life Therapeutic ConjugatesOct 29, 2021Pending
18/018,218Serum Half-Life Extended PD-L1 Inhibitory PolypeptidesJul 30, 2021Pending
18/018,208Serum Albumin-Binding PolypeptidesJul 30, 2021Pending
15/734,445Jun 4, 2019Pending
17/046,646Apr 11, 2019No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited